[1] Weng LC, Preis SR, Hulme OL, et al. Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation[J]. Circulation, 2018, 137(10): 1027-1038. [2] Perger E, Pengo MF, Lombardi C. Hypertension and atrial fibrillation in obstructive sleep apnea: Is it a menopause issue? [J]. Maturitas, 2019, 124: 32-34. [3] Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. [4] Hohl M, Linz B, Böhm M, et al. Obstructive sleep apnea and atrial arrhythmogenesis[J]. Curr Cardiol Rev, 2014, 10(4): 362-368. [5] Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation[J]. Trends Cardiovasc Med, 2015, 25(6): 475-484. [6] 关兵才, 张海林, 李之望, 等. 细胞电生理学基本原理与膜片钳技术[M]. 2013版, 北京科学出版社. [7] Dehghani-Samani A, Madreseh-Ghahfarokhi S, Dehghani-Samani A. Mutations of voltage-gated ionic channels and risk of severe cardiac arrhythmias[J]. Acta Cardiol Sin, 2019, 35(2): 99-110. [8] Dun W, Boyden PA. Aged atria: electrical remodeling conducive to atrial fibrillation[J]. J Interv Card Electrophysiol, 2009, 25(1): 9-18. [9] Zhang K, Ma Z, Wang W, et al. Effect of doxycycline on chronic intermittent hypoxia-induced atrial remodeling in rats[J]. Herz, 2018, 45(7): 668-675. [10] Savio-Galimberti E, Argenziano M, Antzelevitch C. Cardiac arrhythmias related to sodium channel dysfunction[J]. Handb Exp Pharmacol, 2018, 246: 331-354. [11] Hayashi K, Tada H, Yamagishi M. The genetics of atrial fibrillation[J]. Curr Opin Cardiol, 2017, 32(1): 10-16. [12] Wang X, Li G. Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation[J]. J Renin Angio Aldo Syst, 2018, 19(1): 1-8. [13] 唐惠芳, 周斐然, 邓春玉, 等. 咪达普利对舒张功能不全大鼠心房肌细胞钠通道的影响[J]. 实用医学杂志, 2013, 29(9): 1403-1405. [14] Henry BL, Gabris B, Li Q, et al. Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels[J]. Heart Rhythm, 2016, 13(4): 983-991. [15] Liu C, Liu R, Fu H, et al. Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits[J]. Cardiovasc Ther, 2017, 35(5): e12284-12293. [16] Cheng H, Cannell MB, Hancox JC. Differential responses of rabbit ventricular and atrial transient outward current (Ito) to the Ito modulator NS5806[J]. Physiol Rep, 2017, 5(5): e13172-13188. [17] Bosch RF, Zeng X, Grammer JB, et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation[J]. Cardiovasc Res, 1999, 44(1): 121-131. [18] 葛 敏, 单 锋, 唐 碧, 等. 二十二碳六烯酸对心房颤动大鼠心房肌生理改变及双孔钾通道TASK-1蛋白表达的影响[J]. 中国应用生理学杂志, 2016, 32(2): 128-131. [19] 田香勤, 谭朝阳, 李娜娜, 等. 钙激活氯通道蛋白ANO1在心肌成纤维细胞分化过程中的表达及其钙激活氯通道电生理特性变化[J]. 中国应用生理学杂志, 2020, 36(4): 358-362. [20] Workman AJ, Kane KA, Rankin AC. Cellular bases for human atrial fibrillation[J]. Heart Rhythm, 2008, 5(6 Suppl): S1-6. |